世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038161

欧州の糖尿病性足潰瘍市場‐2030年までの予測

The Insight Partners

Europe Diabetic Foot Ulcer Market Forecast to 2030

発刊日 2024/02

言語英語

体裁PDF/126ページ

ライセンス/価格126ページ

0000038161

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ヨーロッパの糖尿病性足潰瘍市場は、2022 年に 18 億 3,731 万ドルと評価され、2030 年までに 29 億 2,475 万ドルに達すると予想されます。 2022 年から 2030 年までのCAGRは6.0% と推定されます。

欧州の糖尿病性足潰瘍市場の概要

ヨーロッパの糖尿病性足潰瘍市場は、2022年から2030年までCAGR 6.0%で成長すると推定されています。市場の成長を牽引する主な要因は、糖尿病および関連する慢性創傷の有病率の増加と、高齢者人口の増加です。高度な創傷治療のコストが高いことが市場の成長を妨げています。しかし、2022年に欧州議会がとった取り組みでは、欧州における糖尿病の予防、管理、より良い糖尿病ケアに重点を置く糖尿病決議の野心的な動議も採択されました。この決議は加盟国に対し、公平な治療へのアクセス、一次および二次医療、糖尿病教育を確保するための国家的な糖尿病計画と戦略を策定、実施、監視するよう求めています。この決議は、これらの目標を達成するために欧州のより強力なリーダーシップと加盟国との協力を求めています。したがって、これらの政府の取り組みは市場の成長を促進すると予想されます。

高齢者は糖尿病に罹りやすいため、高齢者人口の増加が市場の成長に寄与すると考えられます。国家統計局によると、英国の65歳以上の人口は2011年の920万人から2021年には1100万人以上に増加しました。同様に、aarpinternational.org によると、ドイツは世界中で 5 つの「超高齢化」社会の 1 つであり、今後も成長し続けるでしょう。 2050 年までに、人口の 3 分の 1 が 65 歳以上になります。したがって、ヨーロッパにおける糖尿病の有病率の増加と高齢者人口の増加は、糖尿病性足潰瘍市場の成長を促進するでしょう。

レポート詳細

目次

Table of Content

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary
2.1 Key Insights

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Diabetic Foot Ulcer Market Landscape
4.1 Overview

5. Europe Diabetic Foot Ulcer Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Surge in Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:

6. Diabetic Foot Ulcer Market- Europe Market Analysis
6.1 Europe Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type
7.1 Overview
7.2 Europe Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.4 Hydrofiber Dressings
7.3.4.1 Overview
7.3.4.2 Hydrofiber Dressings: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.7 Film Dressing
7.3.7.1 Overview
7.3.7.2 Film Dressing: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.3.8 Other Dressings
7.3.8.1 Overview
7.3.8.2 Other Dressing: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5.4 Ultrasound Therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound Therapy: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Diabetic Foot Ulcer market - Revenue and Forecast to 2030 - By Ulcer Type
8.1 Overview
8.2 Europe Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity
9.1 Overview
9.2 Europe Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
9.3.1 Overview
9.3.2 Mild: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Moderate: Europe diabetic foot ulcer market - Revenue and Forecast to 2030 (US$ Million)
9.3.4 Severe: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User
10.1 Overview
10.2 Europe Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
10.5.1 Overview
10.5.2 Home Care: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market -Europe Country Analysis
11.1 Europe Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 Europe Diabetic Foot Ulcer Market by Country
11.1.1.2 Germany
11.1.1.2.1 Germany Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 Germany Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.2.3 Germany Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.2.3.1 Germany: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.2.3.2 Germany: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.2.3.3 Germany: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.2.4 Germany Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.2.5 Germany Diabetic Foot Ulcer Market, by End User
11.1.1.3 UK
11.1.1.3.1 UK Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 UK Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.3.3 UK Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.3.3.1 UK: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.3.3.2 UK: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.3.3.3 UK: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.3.4 UK Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.3.5 UK Diabetic Foot Ulcer Market, by End User
11.1.1.4 France
11.1.1.4.1 France Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 France Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.4.3 France Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.4.3.1 France: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.4.3.2 France: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.4.3.3 France: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.4.4 France Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.4.5 France Diabetic Foot Ulcer Market, by End User
11.1.1.5 Italy
11.1.1.5.1 Italy Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.2 Italy Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.5.3 Italy Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.5.3.1 Italy: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.5.3.2 Italy: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.5.3.3 Italy: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.5.4 Italy Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.5.5 Italy Diabetic Foot Ulcer Market, by End User
11.1.1.6 Spain
11.1.1.6.1 Spain Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.2 Spain Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.6.3 Spain Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.6.3.1 Spain: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.6.3.2 Spain: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.6.3.3 Spain: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.6.4 Spain Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.6.5 Spain Diabetic Foot Ulcer Market, by End User
11.1.1.7 Rest of Europe
11.1.1.7.1 Rest of Europe Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.7.2 Rest of Europe Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.7.3 Rest of Europe Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.7.3.1 Rest of Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.7.3.2 Rest of Europe: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.7.3.3 Rest of Europe: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.7.4 Rest of Europe Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.7.5 Rest of Europe Diabetic Foot Ulcer Market, by End User

12. Europe Diabetic Foot Ulcer Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Europe Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview

13. Europe Diabetic Foot Ulcer Market - Key Company Profiles
13.1 Convatec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast AS
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun SE
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Molnlycke Health Care AB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MiMedx Group Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Medline Industries LP
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Organogenesis Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix
14.1 About Us
14.2 Glossary of Terms

この商品のレポートナンバー

0000038161

TOP